• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

家庭血液透析中的透析剂量和治疗频率的处方。

Prescribing the dialysis dose and treatment frequency in home haemodialysis.

机构信息

Dialysis Centre SM2, Policoro, Italy.

Nephrology Department, Hospital Universitario de Navarra, Pamplona, Spain.

出版信息

Nephrol Dial Transplant. 2024 Feb 28;39(3):445-452. doi: 10.1093/ndt/gfad212.

DOI:10.1093/ndt/gfad212
PMID:37757455
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10939408/
Abstract

BACKGROUND

There is growing interest in home haemodialysis (HHD) performed with low-flow dialysate devices and variable treatment schedules. The target standard Kt/V (stdKt/V) should be 2.3 volumes/week, according to KDOQI guidelines (2015). The current formula for stdKt/V does not help prescribe the dialysis dose (eKt/V) and treatment frequency (TF). The aim of this study was to obtain a formula for stdKt/V that is able to define the minimum required values of eKt/V and TF to achieve the targeted stdKtV.

METHODS

Thirty-eight prevalent patients on HHD were enrolled. A total of 231 clinical datasets were available for urea modelling using the Solute-Solver software (SS), recommended by KDOQI guidelines. A new formula (stdKt/V = a + b × Kru + c × eKt/V) was obtained from multivariable regression analysis of stdKt/V vs eKt/V and residual kidney urea clearance (Kru). The values of coefficients a, b and c depend on the treatment schedules and the day of the week of blood sampling for the kinetic study (labdayofwk) and then vary for each of their foreseen 62 combinations. For practical purposes, we used only seven combinations, assuming Monday as a labdayofwk for each of the most common schedules of the 7 days of the week.

RESULTS

The stdKt/V values obtained with SS were compared with the paired ones obtained with the formula. The mean ± standard deviation stdKt/V values obtained with SS and the formula were 3.043 ± 0.530 and 2.990 ± 0.553, respectively, with 95% confidence interval +0.15 to -0.26. A 'prescription graph' was built using the formula to draw lines expressing the relationship between Kru and required eKt/V for each TF. Using this graph, TF could have been reduced from the delivered 5.8 ± 0.8 to 4.8 ± 0.8 weekly sessions.

CONCLUSIONS

The new formula for stdKtV is reliable and can support clinicians to prescribe the dialysis dose and TF in patients undergoing HHD.

摘要

背景

使用低流量透析液设备和可变治疗方案进行家庭血液透析(HHD)越来越受到关注。根据 KDOQI 指南(2015 年),目标标准 Kt/V(stdKt/V)应为 2.3 体积/周。目前的 stdKt/V 公式无助于规定透析剂量(eKt/V)和治疗频率(TF)。本研究旨在获得一个能够定义达到目标 stdKtV 所需的最低 eKt/V 和 TF 值的 stdKt/V 公式。

方法

纳入 38 名接受 HHD 的患者。共有 231 例临床数据集可用于使用 KDOQI 指南推荐的 Solute-Solver 软件(SS)进行尿素建模。通过多变量回归分析 stdKt/V 与 eKt/V 和残余肾尿素清除率(Kru),从 SS 获得了一个新的公式(stdKt/V=a+b×Kru+c×eKt/V)。系数 a、b 和 c 的值取决于治疗方案和动力学研究的采血日(labdayofwk),然后因每个预期的 62 种组合而有所不同。出于实际目的,我们仅使用了七种组合,假设每周的星期一为 labdayofwk,适用于每周的七种最常见方案中的每一种。

结果

用 SS 得到的 stdKt/V 值与用公式得到的配对值进行了比较。SS 和公式得到的平均标准偏差 stdKt/V 值分别为 3.043±0.530 和 2.990±0.553,95%置信区间为+0.15 至-0.26。使用该公式绘制了一条表示 Kru 与每个 TF 所需 eKt/V 之间关系的“处方图”。使用该图,TF 可以从每周 5.8±0.8 次减少到 4.8±0.8 次。

结论

新的 stdKtV 公式可靠,可帮助临床医生为接受 HHD 的患者规定透析剂量和 TF。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de2c/10939408/5e8cc2b151ef/gfad212fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de2c/10939408/ed104cb39400/gfad212fig1g.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de2c/10939408/0ab516f8c5f2/gfad212fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de2c/10939408/436053afda16/gfad212fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de2c/10939408/1fec1e663de4/gfad212fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de2c/10939408/5e8cc2b151ef/gfad212fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de2c/10939408/ed104cb39400/gfad212fig1g.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de2c/10939408/0ab516f8c5f2/gfad212fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de2c/10939408/436053afda16/gfad212fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de2c/10939408/1fec1e663de4/gfad212fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/de2c/10939408/5e8cc2b151ef/gfad212fig4.jpg

相似文献

1
Prescribing the dialysis dose and treatment frequency in home haemodialysis.家庭血液透析中的透析剂量和治疗频率的处方。
Nephrol Dial Transplant. 2024 Feb 28;39(3):445-452. doi: 10.1093/ndt/gfad212.
2
The variable target model: a paradigm shift in the incremental haemodialysis prescription.可变目标模型:递增式血液透析处方的范式转变。
Nephrol Dial Transplant. 2017 Jan 1;32(1):182-190. doi: 10.1093/ndt/gfw339.
3
The lacking equation that estimates the protein catabolic rate in patients on once-weekly haemodialysis.缺乏用于估算每周一次血液透析患者蛋白质分解代谢率的方程。
J Nephrol. 2021 Apr;34(2):459-464. doi: 10.1007/s40620-020-00843-9. Epub 2020 Oct 27.
4
Effect of treatment frequency on haemodialysis dose: comparison of EKR and stdKt/V.治疗频率对血液透析剂量的影响:EKR与标准Kt/V的比较
Nephrol Dial Transplant. 2009 Sep;24(9):2797-803. doi: 10.1093/ndt/gfp177. Epub 2009 Apr 22.
5
Routine assessment of kidney urea clearance, dialysis dose and protein catabolic rate in the once-weekly haemodialysis regimen.在每周一次血液透析方案中,常规评估肾脏尿素清除率、透析剂量和蛋白质分解率。
J Nephrol. 2021 Dec;34(6):2009-2015. doi: 10.1007/s40620-021-01033-x. Epub 2021 Apr 23.
6
Validation of formulas calculating normalized protein catabolic rate in patients undergoing home hemodialysis.验证用于行居家血液透析患者的标准化蛋白分解率计算公式。
J Nephrol. 2023 Sep;36(7):1965-1974. doi: 10.1007/s40620-023-01674-0. Epub 2023 Jun 21.
7
Adequacy of quotidian hemodialysis.每日血液透析的充分性
Am J Kidney Dis. 2003 Jul;42(1 Suppl):42-8. doi: 10.1016/s0272-6386(03)00537-7.
8
Improving the "second generation Daugirdas equation" to estimate Kt/V on the once-weekly haemodialysis schedule.改进“第二代 Daugirdas 方程”以估计每周一次血液透析方案的 Kt/V。
J Nephrol. 2021 Jun;34(3):907-912. doi: 10.1007/s40620-020-00936-5. Epub 2021 Jan 30.
9
Standard Kt/Vurea: a method of calculation that includes effects of fluid removal and residual kidney clearance.标准 Kt/Vurea:一种计算方法,包括液体清除和残余肾清除的影响。
Kidney Int. 2010 Apr;77(7):637-44. doi: 10.1038/ki.2009.525. Epub 2010 Jan 27.
10
Predicting treatment dose for novel therapies using urea standard Kt/V.使用尿素标准化Kt/V预测新型疗法的治疗剂量。
Semin Dial. 2004 Mar-Apr;17(2):142-5. doi: 10.1111/j.0894-0959.2004.17212.x.

引用本文的文献

1
Twice Weekly versus Thrice Weekly Hemodialysis-A Pilot Cross-Over Equivalence Trial.每周两次与每周三次血液透析——一项交叉等效性试验的初步研究
Clin J Am Soc Nephrol. 2024 Sep 1;19(9):1159-1168. doi: 10.2215/CJN.0000000000000507. Epub 2024 Jun 26.

本文引用的文献

1
Validation of formulas calculating normalized protein catabolic rate in patients undergoing home hemodialysis.验证用于行居家血液透析患者的标准化蛋白分解率计算公式。
J Nephrol. 2023 Sep;36(7):1965-1974. doi: 10.1007/s40620-023-01674-0. Epub 2023 Jun 21.
2
Towards a tailored prescription of dialysis adequacy: the key role of incremental haemodialysis.迈向个性化的透析充分性处方:递增式血液透析的关键作用。
Nephrol Dial Transplant. 2023 Mar 31;38(4):855-857. doi: 10.1093/ndt/gfac281.
3
Why and how should we promote home dialysis for patients with end-stage kidney disease during and after the coronavirus 2019 disease pandemic? A French perspective.
为何以及如何应在 2019 冠状病毒病大流行期间和之后提倡终末期肾病患者进行家庭透析?法国的观点。
J Nephrol. 2021 Aug;34(4):985-989. doi: 10.1007/s40620-021-01061-7. Epub 2021 Jun 1.
4
Renal Association Clinical Practice Guideline on Haemodialysis.英国肾脏病学会血液透析临床实践指南
BMC Nephrol. 2019 Oct 17;20(1):379. doi: 10.1186/s12882-019-1527-3.
5
Dialysis initiation, modality choice, access, and prescription: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.透析起始、方式选择、通路和处方:肾脏病:改善全球预后组织(KDIGO)争议会议的结论。
Kidney Int. 2019 Jul;96(1):37-47. doi: 10.1016/j.kint.2019.01.017. Epub 2019 Apr 13.
6
Home hemodialysis treatment and outcomes: retrospective analysis of the Knowledge to Improve Home Dialysis Network in Europe (KIHDNEy) cohort.家庭血液透析治疗及结果:欧洲改善家庭透析网络知识(KIHDNEy)队列的回顾性分析
BMC Nephrol. 2018 Oct 11;19(1):262. doi: 10.1186/s12882-018-1059-2.
7
The variable target model: a paradigm shift in the incremental haemodialysis prescription.可变目标模型:递增式血液透析处方的范式转变。
Nephrol Dial Transplant. 2017 Jan 1;32(1):182-190. doi: 10.1093/ndt/gfw339.
8
Solute solver 'what if' module for modeling urea kinetics.用于模拟尿素动力学的溶质求解器“假设”模块。
Nephrol Dial Transplant. 2016 Nov;31(11):1934-1937. doi: 10.1093/ndt/gfw311. Epub 2016 Sep 1.
9
KDOQI Clinical Practice Guideline for Hemodialysis Adequacy: 2015 update.KDOQI 临床实践指南:血液透析充分性 2015 年更新版。
Am J Kidney Dis. 2015 Nov;66(5):884-930. doi: 10.1053/j.ajkd.2015.07.015.
10
Psychosocial aspects in home hemodialysis: a review.家庭血液透析中的社会心理因素:综述
Hemodial Int. 2015 Apr;19 Suppl 1:S128-34. doi: 10.1111/hdi.12258.